Effective August 31 2016, in a continuing effort to optimize our offerings, these changes will be made.
The following will be discontinued:
- Alpha-Galactosidase A Enzyme Analysis on skin fibroblasts (TC 4516)
- Alpha-Galactosidase A Enzyme Analysis on WBC (TC 4517)
- Arylsulfatase A Enzyme Analysis on skin fibroblasts (TC 4537)
- Arylsulfatase A Enzyme Analysis on WBC (TC 4538)
- Beta-Glucosidase Enzyme Analysis on skin fibroblasts (TC 4553)
- Beta-Glucosidase Enzyme Analysis on WBC (TC 4554)
- Citrulline Incorporation into Protein on amniotic fluid (TC 4558)
- Citrulline Incorporation into Protein on CVS (TC 4559)
- Citrulline Incorporation into Protein on skin fibroblasts (TC 4560)
- Galactocerebrosidase Enzyme Analysis on skin fibroblasts (TC 4565)
- Galactocerebrosidase Enzyme Analysis on WBC (TC 4566)
- Alpha-L-iduronidase Enzyme Analysis on skin fibroblasts (TC 4575)
- Alpha-L-iduronidase Enzyme Analysis on WBC (TC 4576)
- Sphingomyelinase Enzyme Assay on skin fibroblasts (TC 4607)
- Sphingomyelinase Enzyme Assay on WBC (TC 4608)
For the Citrulline Incorporation into Protein on amniotic fluid, an alternative test is available:
- Amniotic Fluid Amino Acid Analysis (TC 4170). Please contact us to obtain more information about this test.
